☆ 4.8 Editorial Material

Efficient Trial Design - FDA Approval of Valbenazine for Tardive Dyskinesia

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Journal

NEW ENGLAND JOURNAL OF MEDICINE

Volume 376, Issue 26, Pages 2503-2506

Publisher

MASSACHUSETTS MEDICAL SOC

DOI: 10.1056/NEJMp1704898

Keywords

-

Categories

Medicine, General & Internal

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.